MO1-3 Real-world data of first-line treatment with pembrolizumab for NSCLC with high PD-L1 expression (HOT/NJLCG2001 secondary report)Kazunari Tateishi,Hidenori Mizugaki,Yasuyuki Ikezawa,Ryo Morita,Keiki Yokoo,Toshiyuki Sumi,Hajime Kikuchi,Yasuo Kitamura,Atsushi Nakamura,Maki Kobayashi,Mari Aso,Nozomu Kimura,Fumiaki Yoshiike,Megumi Furuta,Hisashi Tanaka,Motoki Sekikawa,Tsutomu Hashiya,Yuka Fujita,Satoshi OizumiAnnals of Oncology（2023）引用 0|浏览0暂无评分关键词pembrolizumab,real-world,first-lineAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
